JPMorgan Chase & Co. lifted its position in shares of NutriSystem Inc. (NASDAQ:NTRI) by 500.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 182,210 shares of the company’s stock after purchasing an additional 151,882 shares during the period. JPMorgan Chase & Co.’s holdings in NutriSystem were worth $6,751,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. lifted its position in shares of NutriSystem by 6.7% during the second quarter. BlackRock Inc. now owns 4,346,504 shares of the company’s stock worth $167,340,000 after purchasing an additional 274,721 shares in the last quarter. Frontier Capital Management Co. LLC raised its holdings in NutriSystem by 41.3% in the third quarter. Frontier Capital Management Co. LLC now owns 602,313 shares of the company’s stock valued at $22,316,000 after acquiring an additional 176,003 shares in the last quarter. Penserra Capital Management LLC raised its holdings in NutriSystem by 20.2% in the third quarter. Penserra Capital Management LLC now owns 494,690 shares of the company’s stock valued at $18,328,000 after acquiring an additional 83,196 shares in the last quarter. Northern Trust Corp raised its holdings in NutriSystem by 1.5% in the second quarter. Northern Trust Corp now owns 448,770 shares of the company’s stock valued at $17,278,000 after acquiring an additional 6,618 shares in the last quarter. Finally, State of New Jersey Common Pension Fund D raised its holdings in NutriSystem by 9.3% in the third quarter. State of New Jersey Common Pension Fund D now owns 410,000 shares of the company’s stock valued at $15,191,000 after acquiring an additional 35,000 shares in the last quarter.
NTRI opened at $43.81 on Friday. The firm has a market capitalization of $1.29 billion, a P/E ratio of 22.82, a P/E/G ratio of 1.66 and a beta of 1.04. NutriSystem Inc. has a 12-month low of $26.06 and a 12-month high of $55.10.
NutriSystem (NASDAQ:NTRI) last released its earnings results on Tuesday, October 30th. The company reported $0.54 earnings per share for the quarter, meeting the consensus estimate of $0.54. NutriSystem had a net margin of 8.06% and a return on equity of 43.46%. The firm had revenue of $159.30 million during the quarter, compared to analyst estimates of $164.18 million. During the same quarter in the previous year, the firm earned $0.49 earnings per share. The firm’s revenue for the quarter was up .8% compared to the same quarter last year. Equities analysts predict that NutriSystem Inc. will post 2.12 EPS for the current fiscal year.
NutriSystem announced that its board has authorized a stock repurchase plan on Tuesday, October 30th that allows the company to buyback $75.00 million in shares. This buyback authorization allows the company to reacquire up to 7.7% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s board of directors believes its shares are undervalued.
The firm also recently announced a quarterly dividend, which was paid on Monday, November 19th. Shareholders of record on Friday, November 9th were paid a dividend of $0.25 per share. The ex-dividend date was Thursday, November 8th. This represents a $1.00 annualized dividend and a yield of 2.28%. NutriSystem’s payout ratio is 51.02%.
Several research firms recently issued reports on NTRI. ValuEngine raised shares of NutriSystem from a “sell” rating to a “hold” rating in a report on Tuesday, December 11th. B. Riley reaffirmed a “neutral” rating and issued a $45.00 price target (down from $52.00) on shares of NutriSystem in a report on Tuesday, December 11th. Zacks Investment Research raised shares of NutriSystem from a “sell” rating to a “hold” rating in a report on Tuesday, November 6th. Barrington Research cut shares of NutriSystem from an “outperform” rating to a “market perform” rating and set a $44.00 price target on the stock. in a report on Monday, December 10th. Finally, Sidoti cut shares of NutriSystem from a “buy” rating to a “neutral” rating in a report on Monday, December 10th. Nine research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $43.71.
ILLEGAL ACTIVITY WARNING: “JPMorgan Chase & Co. Purchases 151,882 Shares of NutriSystem Inc. (NTRI)” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/12/16/jpmorgan-chase-co-purchases-151882-shares-of-nutrisystem-inc-ntri.html.
Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a D' kit that offers individuals with or at risk of type 2 diabetes.
Recommended Story: What are catch-up contributions?
Want to see what other hedge funds are holding NTRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NutriSystem Inc. (NASDAQ:NTRI).
Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.